Mysite 사이트 그룹

A unique trend in 2026 is the focus on Ethno-specific Biopharmaceuticals. Historically, many biologics were tested primarily on Caucasian populations. South American researchers are now using the "Lati-Genomics" database to tailor treatments to the region's diverse genetic makeup.

This research is particularly active in Chile and Colombia, where scientists are identifying how different indigenous and mestizo genetic markers influence the efficacy of biological drugs. This "Precision Biopharma" approach ensures that dosages and formulations are optimized for the South American metabolic profile, reducing adverse reactions and improving patient outcomes.